Diacylglycerol (DAG) Signaling Role in Synaptic Plasticity
Introduction of DAG
Diacylglycerol (DAG) is made up of a glycerol backbone esterified with two fatty acids, giving rise to the formation of three stereochemical isoforms namely sn-1,2-DAG, sn1,3-DAG, and sn-2,3-DAG. Among the three isomers, 1,3-DAG is thermodynamically more stable as compared to 1,2-(2,3-)-DAG due to the steric hindrance effect. Hence, it is common to end up with an equilibrium mixture of 30-40% 1,2-(2,3-) DAG and 60-70% 1,3-DAG. sn-1,2-Diacylglycerol is the most studied diradylglycerol in mammalian cells. The lipid plays a key role in lipid biosynthesis, in particular of phospholipids and triglycerides, but its individual significance is a consequence of its identification as the physiological activator of protein kinase C (PKC). There are three diradylglycerols in mammalian cells, alkyl, acyl-glycerol, alkenyl, acyl-glycerol, and DAG.
Fig.1 Metabolic pathway of DAG digestion. (Lee, 2020)
Introduction of Synaptic Plasticity
This plasticity determines the ability to alter responsiveness under the influence of successive stimuli, either directly or in association with other factors. Plasticity is the fundamental and most specific functional characteristic of nerve cells, switching on diverse changes in the functioning of neurons. The plastic alterations result in prolonged cellular and synaptic function modifications, which allow us to explain simple modifications of behavioral reactions. The plasticity of the neuron can manifest in the form of a temporary alteration in its responsiveness, either depression or an enhancement. These forms of plasticity, in turn, can be classified into synaptic forms presupposing previous synaptic activation and nonsynaptic forms, which occur when plasticity arises after direct (chemical or electrical) stimulation of the neuron.
DAG Signaling Role in Synaptic Plasticity
It has been long recognized that lipids play important roles in a number of physiological functions. The discovery of the phosphatidylinositol (PtdIns) cycle in neurons accelerated research on the role of lipids in neurobiology. The canonical view of the PtdIns cycle involves the stimulated hydrolysis of phosphatidylinositol-(4,5) bisphosphate PtdIns(4,5)P2 which leads to the generation of inositol (1,4,5) trisphosphate (IP3) and DAG. This system, along with an influx of extracellular calcium provides a mechanism for stimulated increases in calcium and DAG during neuronal stimulation. The DAG generated in this cycle is converted to phosphatidic acid (PtdOH) which is subsequently used for the re-synthesis of PtdIns. Enzymes capable of coordinately regulating the levels of these two lipids are the diacylglycerol kinases (DGKs). These enzymes are organized into five classes or Types based upon similarities in their primary sequence. All DGKs catalyze the transfer of the γ-phosphate of ATP to the hydroxyl group of DAG thereby generating PtdOH while reducing DAG. The notion that these enzymes play important neuronal roles is supported by the observations that eight of the 10 mammalian DGK isozymes are readily detected in the mammalian central nervous system (CNS).
Fig.2 Possible distinct functions of DGK isoforms, and their general role as a coordinator of synaptic plasticity. (Lee, 2016)
Table 1. Involvement of DGK isoforms in several forms of synaptic plasticity.
DGK isoform |
Synapse | Localization | Tested forms of synaptic plasticity | Reported effects in KO mice | Known/expected functions of DGKs |
DGKε | Perforant path-dentate granule cell synapses | N.D. | LTP | Reduction | Regulating amounts of DAG and PKC activity required for LTP, and regulating the lipid signaling leading to the production of retrograde messengers required for LTP |
DGKζ | Hippocampal SC-CA1 synapses | Postsynaptic density | Postsynaptic LTP | Enhancement | Regulating amounts of DAG produced by mGluR activation, and balancing PKC activity, which is a modulator of LTP and LTD |
Postsynaptic LTD | Reduction | – | |||
DGKβ | Hippocampal SC-CA1 synapses | Membranes including synaptic areas | Postsynaptic LTP | Reduction | Regulating basal DAG levels |
DGKι | Hippocampal SC-CA1 synapses | Presynaptic areas | Presynaptic LTD | Reduction | Reducing DAG levels and consequently preventing the activation of target molecules that antagonize LTD |
DGKκ | Hippocampal SC-CA1 synapses | N.D. | Postsynaptic LTP | Reduction | Regulating basal DAG levels |
Postsynaptic LTD | Enhancement | – | |||
DGKζ |
Cerebellar parallel fiber-Purkinje cell synapses |
Postsynaptic areas | Postsynaptic LTP | Normal | – |
Postsynaptic LTD | Reduction | Targeting PKCα required for LTD at synapses, maintaining optimal PKCα activity levels via reducing basal DAG levels, and receiving inhibition from PKCα |
Creative Biolabs is an experienced neuro-based service and products provider. We have rich experience in neuro research and have established a neuro-based platform providing relevant products as well as services. Every effort we made is to provide our customers with a comprehensive and comfortable one-stop service.
If you are interested in neuro researches and relevant services, or you have any other questions, please don’t hesitate to contact us for more information.
Reference
- Lee, D., et al. Diacylglycerol Kinases in the Coordination of Synaptic Plasticity. Front Cell Dev Biol. 2016, 4: 92.
- NeuroMab™ Anti-TNFα BBB Shuttle Antibody(NRZP-1022-ZP4105) (Cat#: NRZP-1022-ZP4105)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- NeuroMab™ Anti-pTau Antibody(NRP-0422-P1719) (Cat#: NRP-0422-P1719)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- NeuroMab™ Anti-GARP Antibody(NRP-0422-P1639) (Cat#: NRP-0422-P1639)
- NeuroMab™ Anti-CD20 Antibody(NRP-0422-P1230) (Cat#: NRP-0422-P1230)
- NeuroMab™ Anti-TREM2 BBB Shuttle Antibody(NRZP-1022-ZP4114) (Cat#: NRZP-1022-ZP4114)
- NeuroMab™ Anti-CD32b Antibody(NRP-0422-P1803) (Cat#: NRP-0422-P1803)
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- Rat Microglia Cell Line HAPI, Immortalized (Cat#: NCL2110P015)
- Rat Immortalized Retinal Muller Cell Line rMC-1 (Cat#: NCL-2106-S93)
- iNeu™ Human Motor Neurons (Cat#: NCL-2103-P71)
- Human Brain Astroblastoma U-87 MG (Cat#: NCL2110P117)
- Human Microglia Cell Line HMC3, Immortalized (Cat#: NCL-2108P38)
- Mouse Retinal Ganglion Cells (Cat#: NCL2110P145)
- iNeu™ Human Neural Stem Cell Line (Cat#: NCL200552ZP)
- Green Fluorescent BACE1 Cell Lines (Cat#: NCL2110P214)
- Rat Retinal Muller Cell Line, Immortalized (Cat#: NCL-21P6-192)
- Human Retinal Epithelial Cell ARPE-19 (Cat#: NCL2110P069)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- rAAV-E-SARE-Cre-ERT2-PEST-WPRE-hGH polyA (Cat#: NTA-2010-TT342)
- pAAV-syn-FLEX-jGCaMP8s-WPRE (Cat#: NTA-2106-P066)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- pAAV-syn-FLEX-jGCaMP8f-WPRE (Cat#: NTA-2106-P064)
- pAAV-syn-jGCaMP8m-WPRE (Cat#: NTA-2106-P062)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- pAAV-syn-FLEX-jGCaMP8m-WPRE (Cat#: NTA-2106-P065)
- Dextran, NHS Activated, 40 kDa (Cat#: NRZP-0722-ZP124)
- pAAV-hSyn-DIO-XCaMP-R-WPRE (Cat#: NTA-2012AD-P508)
- Dextran, Cy5 Labeled, 2000 kDa (Cat#: NRZP-0722-ZP22)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)